FDA Protects Chinese Supplier of Tainted Heparin, Refuses to Release Names

Email this article to a friend

Printable Version

Articles Related to This Article: • Heparin Blood Thinner Drug Linked to Sudden Deaths; Cheap Ingredients Imported from Chinese Chemical Factory • Dennis Quaid's Children Nearly Killed by Heparin Drug • Heparin Contamination Fiasco Reveals Dirty Secret of Drug Industry: Their Pills are Made in China! Support NaturalNews advertisers - Advertise with NaturalNews Help support NaturalNews with health books and educational programs from Truth Publishing: • Swine Flu Advanced Preparedness • 8 Weeks to Vibrant Health • Raw In Ten Minutes (recipes) • How to Halt Diabetes in 25 Days ... and much more.

(NaturalNews) The FDA has come into conflict with Congressional investigators over its refusal to release information on which Chinese companies supplied a tainted blood thinner that has led to at least 81 deaths in the United States.

Earlier this year, the FDA issued its first alert over tainted supplies of the blood thinner heparin. To date, the contaminated drug has caused allergic reactions that have led to more than 1,000 adverse events in the United States, including 81 confirmed deaths since January 2007. The tainted drugs have also been detected in 10 other countries.

In spite of the original warning, the FDA recently discovered that tainted heparin was still on the shelves in some California hospitals. In response, the alert was widened to include hospitals, physicians groups and pharmaceutical organizations.

"We found it on crash carts, catheter labs, and even on one hospital pharmacist's shelf," said Karen Riley of the FDA.

Heparin is a widely used blood thinner, frequently given in large doses to patients in order to prevent clotting during complex medical procedures such as kidney dialysis or heart surgery. In 2007, then-lead heparin manufacturer Baxter International made $30 million in sales of the drug.

Most of the heparin sold in the United States is manufactured from ingredients made in China, a major supplier of drug ingredients to the United States. According to Baxter Chairman and Chief Executive Robert Parkinson, China is a favored source for heparin in particular, because "that's where the pig population is."

The active ingredient in heparin is derived from pig intestines, and China has five times the pig population of the United States.

The FDA suspects that the deadly heparin originally became contaminated in a Chinese factory, but has refused to tell Congress which companies supplied heparin ingredients to the United States from China. The agency says that confidentiality agreements with the producers bar it from revealing any of their names.

The FDA has determined that the tainted heparin was adulterated with a heparin-like chemical called oversulfated chondroitin sulfate, derived from shellfish. The presence of this synthetic chemical suggests that the drugs were deliberately tampered with during the manufacturing process, probably to decrease costs for the supplier. But the FDA does not yet know at what stage in the manufacturing process the chemical was added.

This is only the latest source of conflict between the FDA and Congress over the heparin crisis. From the beginning, members of Congress have criticized the FDA's handling of the situation.

"The FDA thinks they have it under control, but they really don't," said Rep. Bart Stupak. "If I was the FDA director, I'd shut down every drug coming in from China" until each one had individually been proven to be safe.

But the FDA retorted that it does not have the legal authority to prevent the importation of Chinese-manufactured drugs, citing a Memorandum of Agreement that regulates relations between the FDA and China. The memorandum was signed in order to speed the process of allowing FDA inspection of Chinese drug factories in the first place.

Instead, the FDA is relying on companies to voluntarily test their heparin ingredients before distributing them in the United States. Yet such testing failed to reveal the tainted ingredient between January 2007 and February 2008.

Free registration is required to read the rest of this article...
Enter your email address to continue:  
Your email privacy is 100% protected by NaturalNews. We do not sell, rent or share emails.


Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • Heparin Blood Thinner Drug Linked to Sudden Deaths; Cheap Ingredients Imported from Chinese Chemical Factory • Dennis Quaid's Children Nearly Killed by Heparin Drug • Heparin Contamination Fiasco Reveals Dirty Secret of Drug Industry: Their Pills are Made in China!	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/024550_Heparin_the_FDA_Baxter.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/024550_Heparin_the_FDA_Baxter.html">FDA Protects Chinese Supplier of Tainted Heparin, Refuses to Release Names</a>